Company Filing History:
Years Active: 2017-2023
Title: Sydney Gordon: Innovator in Immunotherapy
Introduction
Sydney Gordon is a prominent inventor based in Stanford, California. She has made significant contributions to the field of immunotherapy, particularly through her innovative work on PD-1 agents. With a total of four patents to her name, her research focuses on enhancing immune responses in mammals.
Latest Patents
Among her latest patents is the development of high affinity PD-1 mimic polypeptides. These polypeptides contain at least one amino acid change compared to the wild-type PD-1 protein and exhibit increased affinity for PD-L1. The compositions and methods she has developed aim to modulate the activity of immune cells by administering a therapeutic dose of a pharmaceutical composition that blocks the binding interaction between PD-1 and its ligands, PD-L1 and PD-L2.
Career Highlights
Sydney Gordon is affiliated with Leland Stanford Junior University, where she conducts her research and develops her innovative therapies. Her work has the potential to significantly impact cancer treatment and other immune-related conditions.
Collaborations
She collaborates with notable researchers in her field, including Aaron Michael Ring and Andrew Curtis Kruse. These partnerships enhance the scope and effectiveness of her research efforts.
Conclusion
Sydney Gordon is a trailblazer in the field of immunotherapy, with her innovative patents paving the way for new therapeutic approaches. Her contributions are vital to advancing our understanding and treatment of immune-related diseases.